IP Library › Granted Patent US 11,091,793
Granted Patent B2
US 11,091,793 · App. 16/424,523 · Granted Aug 17, 2021

Detection of hydroxymethylcytosine bases

Inventors: Yuval Ebenstein (Yavne, IL); Micha Fridman (Kiryat Bialik, IL)
Assignee: Ramot at Tel-Aviv University Ltd.
C12Q1/6806C12P19/305G01N21/6428
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,091,793
App. No.
16/424,523
Granted
Aug 17, 2021
Kind
B2
Abstract

Methodologies for labeling the epigenetic modification 5-hydroxymethylcytosine (5hmC) along a DNA molecule, and for determining a presence or a level of this epigenetic modification based on a ratio of fluorescence intensity of a labeled DNA sample to absorption intensity of the DNA sample at 260 nm are disclosed. Related compositions and reagents, and methods of preparing same are also disclosed.

Claims (23)

1. A method of detecting 5-hydroxymethyl-cytosine in a DNA sample, the method comprising:

(a) reacting the DNA sample with a 5-hydroxymethyl-cytosine-specific fluorescent labeling agent under conditions which allow staining of the DNA sample with said 5-hydroxymethyl-cytosine-specific fluorescent labeling agent so as to obtain a 5-hydroxymethyl-cytosine-labeled DNA sample;

(b) measuring fluorescence intensity of said 5-hydroxymethyl-cytosine-labeled DNA sample (X) and absorption intensity of said 5-hydroxymethyl-cytosine-labeled DNA sample at 260 nm (Y), and (c) comparing a ratio between X to Y to a ratiometric calibration curve, to thereby determine a presence or a level of 5-hydroxymethyl-cytosine in the DNA sample.

2. The method of claim 1 , wherein said detecting is effected in a high throughput setting of at least 300 DNA samples.

3. The method of claim 1 , wherein said 5-hydroxymethyl-cytosine specific fluorescent labeling agent comprises a fluorescent moiety covalently attached to a chemical moiety that binds 5-hydroxymethyl-cytosine.

4. The method of claim 1 , not comprising subjecting DNA of said DNA sample or said 5-hydroxymethyl-cytosine-labeled DNA sample to fragmentation.

5. The method of claim 1 , wherein reacting the DNA sample with a 5-hydroxymethyl-cytosine-specific fluorescent labeling agent comprises:

reacting a fluorescent labeling agent derivatized by a second reactive group with a DNA molecule in which the 5-hydroxymethy-cytosines are glycosylated by a glucose molecule derivatized by a first reactive group,

wherein said first and second reactive groups are chemically compatible to one another.

6. The method of claim 5 , further comprising glycosylating the 5-hydroxymethy-cytosines in the DNA molecule comprises incubating the DNA molecule with β-glucosyltransferase and a uridine diphosphoglucose derivatized by said first reactive group.

7. The method of claim 6 , wherein said uridine diphosphoglucose derivatized by said first reactive group is a UDP-6-N 3 -Glucose.

8. The method of claim 7 , wherein said UDP-6-N 3 -Glucose is synthesized chemically.

9. The method of claim 7 , wherein said UDP-6-N 3 -Glucose is synthesized enzymatically.

10. The method of claim 9 , wherein enzymatically synthesizing said UDP-6-N 3 -Glucose comprises subjecting phosphorylated 6-azidoglucose to enzymatic catalysis by uridyltransferase in the presence of UTP.

11. The method of claim 10 , wherein said enzymatically synthesizing said UDP-6-N 3 -Glucose further comprises subjecting 6-azidoglucose to enzymatic catalysis by kinase N-acetylhexoseamine-1-kinase in the presence of ATP, to thereby obtain said phosphorylated 6-azidoglucose.

12. The method of claim 5 , wherein one of said first and second reactive groups is azide and the other is alkyne, such that said 5-hydroxymethyl-cytosine-labeled DNA sample is obtained by a click chemistry.

13. The method of claim 5 , wherein said reacting is free of a copper catalyst.

14. The method of claim 5 , wherein said first reactive group is azide.

15. The method of claim 1 , wherein said DNA sample comprises a genomic DNA molecule.

16. The method of claim 15 , wherein the genomic DNA molecule is longer than 20 Kb.

17. The method of claim 15 , wherein the genomic DNA molecule is longer than 30 Kb.

18. The method of claim 15 , wherein the genomic DNA molecule is longer than 40 Kb.

19. The method of claim 1 , wherein a concentration of DNA in said DNA sample and said 5-hydroxymethyl-cytosine-labeled DNA sample is in a range of from 1 to 350 ng/μl.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2019
From: EBENSTEIN, YUVAL; FRIDMAN, MICHA
To: RAMOT AT TEL-AVIV UNIVERSITY LTD.
Reel/Frame 049560/0153 →
Continuity (3)
Division 14894350
Provisional Application 61828129 · May 28, 2013
Related Publication 20190316178A1 · Oct 17, 2019
Cited By (1)
US 12,630,866